Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease

Clinical Rheumatology

Volumn 26, Issue 6, 2007, Pages 947-949

  Selva O'Callaghan, Albert ^a,b   Balada, Eva ^a   Serrano Acedo, Silvia ^a   Simeon Aznar, Carmen Pilar ^a   Ordi Ros, Josep ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE   (Spain)

Author keywords

ALK 1; Pulmonary hypertension; Rheumatic diseases; Systemic sclerosis

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ACTIVIN RECEPTORS, TYPE II; ADULT; AGED; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MUTATION; SCLERODERMA, DIFFUSE;

EID: 34250768373     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0388-x     Document Type: Article

References (11)

1. Runo JR, Lloyd JE (2003) Primary pulmonary hypertension. Lancet 361:1533-1544
2. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE et al (1997) The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60-67
3. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I et al (2001) Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:325-334
4. Vollmann J, Winau R (1996) Informed consent in human experimentation before the Nuremberg code. BMJ 313:1445-1449
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
6. LeRoy EC, Black C, Fleischmajer R, Jablonska SA, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15:202-205
7. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of the angiogenesis. Proc Natl Acad Sci USA 97:2626-2631
8. Morse JH (2003) Genetic studies of pulmonary arterial hypertension. Lupus 12:209-212
9. Tew MB, Arnett FC, Reveille JD, Tan FK (2002) Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases. Arthritis Rheum 46:2829-2830
10. Morse J, Barst R, Horn E, Cuervo N, Deng Z, Knowles J (2002) Pulmonary hypertension in scleroderma spectrum of disease: Lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 29:2379-2381
11. Satoh T, Kimura K, Okano Y, Hirakata M, Kawakami Y, Kuwana M (2005) Lack of circulating autoantibodies to bone morphogenetic protein receptor II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension. Rheumatology 44:192-196